China's Resorcinol Prices Slides Further in July on Cautious Downstream Buying

China’s Resorcinol market remained under pressure in July 2026, extending the 2.76% decline recorded in June as cautious downstream procurement, comfortable availability, and competitive supplier offers continued to weigh on market sentiment. The correction reflected limited buying momentum across key pharmaceutical, plastics, dyes, and specialty organic chemical applications, with buyers maintaining disciplined inventory positions.

During July, Resorcinol prices declined as demand from major downstream industries remained subdued. Pharmaceutical manufacturers maintained routine procurement of pharmaceutical-grade resorcinol for formulations and specialty applications but purchasing remained largely requirement-based rather than inventory-driven. Demand from plastics and resin manufacturers also remained moderate, as converters and compounders limited fresh purchases amid cautious operating strategies. Dye and pigment producers similarly maintained controlled procurement, while manufacturers of other organic chemicals showed limited interest in building inventories. On the supply side, Chinese producers continued to maintain adequate availability, with no major production disruptions reported during the period. Comfortable inventories allowed Resorcinol suppliers to compete more actively for available orders, while weaker spot enquiries reduced sellers’ pricing leverage. As a result, the balance between sufficient supply and restrained downstream purchasing kept the Resorcinol market on a declining trajectory throughout July.

The July correction followed a 2.76% decline in Resorcinol prices during June, when softer purchasing activity and adequate market availability created similar downward pressure. Pharmaceutical and industrial consumers largely relied on existing inventories and limited spot procurement, while plastics, dyes, and organic chemical producers showed no significant increase in consumption. The absence of major supply disruptions allowed inventories to remain comfortable, encouraging suppliers to offer competitive quotations to maintain sales volumes. Consequently, the market entered July with weak momentum and limited support for a price recovery.

Looking ahead, Resorcinol prices are expected to remain low in August before showing signs of improvement in September. August demand is likely to remain restrained as pharmaceutical, plastics, dye, and organic chemical manufacturers continue disciplined inventory management and avoid aggressive spot procurement. However, buying activity could improve in September as downstream producers begin replenishing stocks and prepare for stronger production schedules toward the final quarter. Pharmaceutical manufacturers may increase Resorcinol procurement to secure raw materials for upcoming formulation requirements, while plastics, dyes, and specialty organic chemical producers could gradually rebuild inventories. Any strengthening in upstream phenolic feedstock costs could further improve producer pricing leverage, although the extent of recovery will depend on actual cost movements. Overall, the Resorcinol market is expected to remain weak in August, followed by a gradual improvement in September as downstream procurement normalizes.